Getagraph.com logo
: ( 0%) 0
S&P 500
(0%) 0 points
Dow Jones
(0%) 0 points
Nasdaq
(0%) 0 points
Oil
(0%) $0
Gas
(0%) $0
Gold
(0%) $0
Silver
(0%) $0
Platinum
(0%) $0
USD/EUR
(0%) $0
USD/NOK
(0%) $0
USD/GBP
(0%) $0
USD/RUB
(0%) $0

Realtime updates for Evotec SE [EVT.DE]

Exchange: XETRA Sector: Life Sciences Tools & Services Industry: Drug Manufacturers—Specialty & Generic
Last Updated
25% discount on Stockinvest.us - Use code: Podcast

0% € 0

Live Chart Being Loaded With Signals

Commentary ():

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health...

Stats
Today's Volume 0
Average Volume 0
Market Cap 0
EPS €0 ( 2024-05-21 )
Next earnings date ( €-0.0700 ) 2024-08-27
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E 0
ATR14 €0 (0.00%)

Evotec SE Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Evotec SE Financials

Annual 2023
Revenue: €781.43M
Gross Profit: €175.05M (22.40 %)
EPS: €-0.470
FY 2023
Revenue: €781.43M
Gross Profit: €175.05M (22.40 %)
EPS: €-0.470
FY 2022
Revenue: €751.45M
Gross Profit: €174.07M (23.16 %)
EPS: €-0.990
FY 2021
Revenue: €618.03M
Gross Profit: €151.54M (24.52 %)
EPS: €1.300

Financial Reports:

No articles found.

Evotec SE Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Evotec SE

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.1470131874084 seconds
Number of API calls: 2
Number of DB calls: 8